A potent inhibitor of angiogenesis, infβ works by blocking interleukin-8 (IL-8), basic fibroblast growth factor (bfgf), and collagenase type v, which are all potent angiogenic factors that aid tumour development and invasiveness. Here, CXCL8 is linked to neoplasm.